AzTrials
AzTrials

Elderly PersonsNCT02196623

Hypoxia and Exercise in the Elderly

A study testing Hypoxic exercise and Normoxic Exercise in people with Elderly Persons, run by Hannover Medical School at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ageing is the primary risk factor for most chronic diseases including type 2 diabetes mellitus. Sarcopenia and muscular mitochondrial dysfunction with aging are crucial mechanisms leading to decreased exercise tolerance and worsened insulin sensitivity. Read more about this study

Who is it for?
Ages 55 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Elderly Persons
What is being tested?
Hypoxic exercise and Normoxic Exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
29 participants
Where
1 siteGermany
Study dates
Jun 2015to Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 55 to 75 years of age
  • body mass index: 20 - 35 kg/m2
  • weight stable during last 6 months before screening (weight change < 2% body weight)
  • HOMA-index of insulin resistance ≥ 2 to 4 units

Who cannot join

  • more than 1 hour of scheduled exercise training per week
  • known diagnosis of type 2 diabetes or measured HbA1c > 6,5%
  • known drug or alcohol abuse
  • any contraindication to perform exercise training
  • acute or chronic infections
  • increased bleeding risk by history, INR > 1,3, use of anticoagulants

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Hannover Medical School

    Hanover, Lower Saxony, 30625

Other trials in Germany

About this study

Official title: Hypoxia and Aerobic Exercise Interactions in Age-related Metabolic Muscle Dysfunction

Ageing is the primary risk factor for most chronic diseases including type 2 diabetes mellitus. Sarcopenia and muscular mitochondrial dysfunction with aging are crucial mechanisms leading to decreased exercise tolerance and worsened insulin sensitivity. Thus, metabolic disease and frailty, which limits physical mobility as well as quality of life, share common cellular mechanisms.

The investigators will test the hypothesis that a combination of normobaric hypoxia and exercise training elicits a synergistic effect on age-associated metabolic skeletal muscle dysfunction and the investigators will address the molecular mechanisms. In a randomized clinical study, the investigators will compare normoxic and hypoxic training conditions in elderly subjects. Outcome measures will focus on whole body insulin sensitivity and mitochondrial responses in skeletal muscle before and after the 8-week training intervention.

Conditions
Elderly Persons
Being tested
Hypoxic exercise, Normoxic Exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypoxic exerciseOther

    Supervised, progressive aerobic exercise program for 8 weeks under hypoxic conditions

  • Normoxic ExerciseOther

    Supervised, progressive aerobic exercise program for 8 weeks under normoxic conditions

Study groups in NCT02196623
Study groupRoleWhat they receive
Hypoxic ExerciseExperimentalSupervised, progressive aerobic exercise for 8 weeks under hypoxic conditions
Receives: Other: Hypoxic exercise
Normoxic exerciseSham comparatorSupervised, progressive aerobic exercise for 8 weeks under normoxic conditions
Receives: Other: Normoxic Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin sensitivity

    Insulin sensitivity is assessed via the hyperinsulinemic euglycemic glucose clamp and expressed as the glucose infusion rate (GIR) in ml

    Measured: At baseline and after 8 weeks

Secondary outcomes (5)
  1. Maximum oxygen uptake

    Maximum oxygen uptake is measured during an incremental exhaustive exercise test and is expressed in ml/min/kg

    Measured: At baseline and after 8 weeks

  2. Mitochondrial number

    Mitochondrial number and selected gene expression assessed from muscle biopsies from the vastus lateralis.

    Measured: At baseline and after 8 weeks

  3. Fat and carbohydrate oxidation during exercise

    Fat and carbohydrate oxidation during exercise is assessed during an incremental exercise test by measurements of gas exchange and expressed as g/min

    Measured: At baseline and after 8 weeks

  4. Body fat and body fat free mass

    Measured via by air-displacement plethysmography (ADP) and expressed in kg

    Measured: At baseline and after 8 weeks

  5. Health related quality of life

    Assessed using the short form 36 (SF-36) questionnaires

    Measured: At baseline and after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2014 (estimated)
  2. Study startJun 2015
  3. Primary completionSep 2017
  4. Study completionJan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02196623
Sponsor's protocol ID
HA 7037/2-1
Status last verified
Aug 2017
First submitted
18 Jul 2014
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
No

Publications

  • Hein M, Chobanyan-Jurgens K, Tegtbur U, Engeli S, Jordan J, Haufe S. Effect of normobaric hypoxic exercise on blood pressure in old individuals. Eur J Appl Physiol. 2021 Mar;121(3):817-825. doi: 10.1007/s00421-020-04572-6. Epub 2020 Dec 23.

    PubMed 33355713
  • Chobanyan-Jurgens K, Scheibe RJ, Potthast AB, Hein M, Smith A, Freund R, Tegtbur U, Das AM, Engeli S, Jordan J, Haufe S. Influences of Hypoxia Exercise on Whole-Body Insulin Sensitivity and Oxidative Metabolism in Older Individuals. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5238-5248. doi: 10.1210/jc.2019-00411.

    PubMed 30942862

Questions about this trial

What is this clinical trial studying?

A study testing Hypoxic exercise and Normoxic Exercise in people with Elderly Persons, run by Hannover Medical School at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin sensitivity (time frame: At baseline and after 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02196623, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in